Published by
The Street
The Street
By GlobeNewswire Fremont, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (ABVC) – Get ABVC BioPharma Inc Report, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Vitargus®, its vitreous substitute intended to facilitate retina re-attachment surgery, received the 2021 “National Innovation and Renewal of Diligence” award from the Institute for Biotechnology and Medicine Industry (IBMI) of Taiwan. The award was presented at the Taiwan Medical Technology Exhibition on De…